Fujian Huitian Bio-pharma is Pharmaceuticals in China that focus on pharmaceutical drugs analgesic business. Founded in 1969. They cover business area such as manufacturer, designer, pharmaceutical drug, autoimmune disease, analgesic drug, thrombin-like enzyme, lipid-lower tablet, related medicine, generic disease, client, quality drug, healthy and disease free life.
1969
( 55 years old in 2024 )
Pharmaceutical Drugs Analgesic
-
Hudong Road
Floor 6,Olympic building
Fuzhou City, Fujian Province
China
Private
manufacturerdesignerpharmaceutical drugautoimmune diseaseanalgesic drugthrombin-like enzymelipid-lower tabletrelated medicinegeneric diseaseclientquality drughealthy and disease free life
* We use standard office opening hours in near Fujian Huitian Bio-pharma's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Fujian Huitian Bio-pharma is Pharmaceuticals business from China that founded in 1969 (55 years old in 2024), Fujian Huitian Bio-pharma business is focusing on Pharmaceutical Drugs Analgesic.
Fujian Huitian Bio-pharma headquarter office and corporate office address is located in Hudong Road Floor 6,Olympic building Fuzhou City, Fujian Province China.
Fujian Huitian Bio-pharma was founded in China.
In 2024, Fujian Huitian Bio-pharma is currently focus on pharmaceutical drugs analgesic sector.
Above is snippet of Google Trends for "pharmaceutical drugs analgesic" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Fujian Huitian Bio-pharma, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
